ResMed Buy or Sell Recommendation

Macroaxis provides ResMed Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ResMed positions. The advice algorithm takes into account all of ResMed Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from ResMed buy-and-hold prospective. Additionally take a look at ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Symbol
Execute Advice
ResMed Inc -- USA Stock  

USD 87.86  0.08  0.0911%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding ResMed Inc is 'Hold'.
For the selected time horizon ResMed Inc has a risk adjusted performance of 0.0757, jensen alpha of 0.1228, total risk alpha of (0.35), sortino ratio of (0.07664) and treynor ratio of 1.57
Macroaxis provides advice on ResMed Inc to complement and cross-verify current analyst consensus on ResMed Inc. Our recommendation engine determines the corporation potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure ResMed is not overpriced, please check all ResMed Inc fundamentals including its Book Value Per Share, Retained Earnings and the relationship between Cash per Share and Number of Employees . Given that ResMed Inc has Price to Earning of 35.38 times, we recommend you check out ResMed Inc market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Returns Distribution Density

Mean Return0.15Value At Risk1.27
Potential Upside1.33Standard Deviation0.85
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Crestwood Advisors Group LlcCommon Shares211.5 K17.9 M
Capital Investment Services Of America IncCommon Shares183.2 K15.5 M
Nisa Investment Advisors LlcCommon Shares99.4 K8.4 M
Tandem Investment Advisors IncCommon Shares81.1 K6.9 M
Oregon Public Employees Retirement FundCommon Shares33.1 K2.8 M
Exxonmobil Investment Management IncCommon Shares22.6 K1.9 M
Bright Rock Capital Management LlcCommon Shares20 K1.7 M
Simplex Trading LlcCall Options64.07 K
Simplex Trading LlcPut Options6.00.0

ResMed Greeks

α
Alpha over DOW
=0.12
β
Beta against DOW=0.0914
σ
Overall volatility
=0.78
Ir
Information ratio =0.1

ResMed Volatility Alert

ResMed Inc has relatively low volatility with skewness of -0.57 and kurtosis of 0.21. However, we advise all investors to independently investigate ResMed Inc to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare ResMed to competition
FundamentalsResMedPeer Average
Return On Equity18.43 % (15.17) %
Return On Asset8.72 % (15.64) %
Profit Margin16.58 % (5.5) %
Operating Margin22.36 % (10.91) %
Current Valuation12.37 B152.14 B
Shares Outstanding141.9 M1.43 B
Shares Owned by Insiders1.2 % 6.91 %
Shares Owned by Institutions65.69 % 18.37 %
Price to Earning35.38 times40.69 times
Price to Book6.04 times14.44 times
Price to Sales5.81 times17.81 times
Revenue2.12 B9.85 B
Gross Profit1.2 B21.75 B
EBITDA589.1 M1.41 B
Net Income352.3 M517.71 M
Cash and Equivalents811.1 M3.89 B
Cash per Share5.72 times5.17 times
Total Debt1.02 B7.36 B
Debt to Equity49.7 % 0.72 %
Current Ratio4.72 times3.3 times
Book Value Per Share14.41 times13.64 times
Cash Flow from Operations421.79 M1.25 B
Earnings Per Share2.46 times2.3 times
Price to Earnings To Growth2.86 times1.22 times
Number of Employees5.25 K10.67 K
Beta0.780.34
Market Capitalization12.35 B29.78 B
Total Asset3.26 B126.86 B
Retained Earnings2.16 B38.24 B
Working Capital781.73 M3.58 B
Current Asset1.42 B36.8 B
Current Liabilities637.99 M33.34 B
Z Score7.2708.73
SellBuy
Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

Inapplicable
   Exercise or conversion by Jacobsen Stein of 37500 shares of ResMed subject to Rule 16b-3 [view details]
Risk Adjusted Performance0.0757
Market Risk Adjusted Performance1.58
Mean Deviation0.6391
Semi Deviation0.726
Downside Deviation1.07
Coefficient Of Variation552.9
Standard Deviation0.8484
Variance0.7198
Information Ratio(0.096924)
Jensen Alpha0.1228
Total Risk Alpha(0.35)
Sortino Ratio(0.07664)
Treynor Ratio1.57
Maximum Drawdown3.44
Value At Risk(1.27)
Potential Upside1.33
Downside Variance1.15
Semi Variance0.527
Expected Short fall(0.65)
Skewness(0.57)
Kurtosis0.205

Current Valuation

ResMed Current Valuation Analysis
ResMed Inc is rated below average in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Medical Equipment industry is at this time estimated at about 118.66 Billion. ResMed retains roughly 12.37 Billion in current valuation claiming about 10% of all equities under Medical Equipment industry.